跳至主要内容
临床试验/IRCT2015060622562N1
IRCT2015060622562N1已完成2 期

The effects of selenium supplementation on advanced glycation end products, biomarkers of inflammatory and oxidative stress in diabetic nephropathy patients in comparison with placebo: a randomized double-blinded controlled clinical trial

Vice chancellor for research, Kashan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 85 years(—)
性别
All

入选标准

  • Diabetic nephropathy with a proteinuria level of >0.3 g/24 hours
  • With or without circulating levels of serum creatinine

排除标准

  • The consumption of selenium supplements within 3 months before beginning of the study
  • Patients with uncontrolled diabetes
  • Pregnant women
  • Liver diseases
  • Inflammatory diseases
  • Bacteriuria
  • Urinary tract infection
  • History of hospital admission within 3 months

研究者

发起方
Vice chancellor for research, Kashan University of Medical Sciences

相似试验

The effect of selenium on nephropathy complications... | 临床试验